Noradrenergic pathology in psychiatric disorders: Postmortem studies

CNS Spectrums

Volumn 6, Issue 8, 2001, Pages 697-703

  Ordway, Gregory A ^a   Klimek, Violetta ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; AMINE OXIDASE (FLAVIN CONTAINING); BETA ADRENERGIC RECEPTOR; NORADRENALIN; NORADRENALIN TRANSPORTER; TYROSINE 3 MONOOXYGENASE;

AUTOPSY; DEPRESSION; DISEASE ASSOCIATION; HUMAN; MENTAL DISEASE; MORPHOMETRICS; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; REVIEW; SUICIDE;

EID: 0035564446     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900001395     Document Type: Review

References (70)

1. The pharmacology and biochemistry of depression
2. The catecholamine hypothesis of affective disorders: A review of supporting evidence
3. CSF and urinary biogenic amines and metabolites in depression and mania: A controlled, univariate analysis
4. Cerebrospinal fluid amine metabolites: Relationships with behavioral measurements in depressed, manic, and healthy control subjects
5. Urinary MHPG in subgroups of depressed patients and normal controls
6. Plasma norepinephrine level in affective disorders: Relationship to melancholia
7. Sympathetic nervous system activity in major depression: Basal and desipramine-induced alterations in plasma norepinephrine kinetics
8. Monoamine dysfunction and the pathophysiology and treatment of depression
9. Lack of behavioral effects of monoamine depletion in healthy subjects
10. Depression: The case for a monoamine deficiency
11. Transient depressive relapse induced by catecholamine depletion
12. Brain noradrenaline and schizophrenia
13. Schizophrenia and the frontal lobe
14. DSP4-induced two-way active avoidance impairment in rats: Involvement of central and not peripheral nopadrenaline depletion
15. Mason ST Noradrenaline in the brain: Progress in theories of behavioural function
16. Rotational behavior produced by unilateral ventral noradrenergic bundle lesions: Evidence for a noradrenergic-dopaminergic interaction in the brain
17. Schizophrenia: Elevated cerebrospinal fluid norepinephrine
18. The effect of pimozide on CSF norepinephrine in schizophrenia
19. Impaired noradrenergic transmission in schizophrenia?
20. San Diego suicide study
21. Monoamine receptors in postmortem brain tissue in suicide
22. Brain alpha-adrenoceptors in depressed suicides
23. Quantitative autoradiography of al and a2 adrenergic receptors in the cerebral cortex of controls and suicide victims
24. Autoradiographic analysis of alpha 1-noradrenergic receptors in the human brain postmortem. Effect of suicide
25. Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides
26. Brain noradrenergic receptors in major depression and schizophrenia
27. Postmortem neurochemical studies in depression
28. Increased α2-adrenoceptor density in the frontal cortex of depressed suicide victims
29. Alpha2-adrenoceptors in the brain of suicide victims: Increased receptor density associated with major depression
30. Is schizophrenia an autoimmune disease
31. Distribution of beta-adrenergic receptor subtypes in human post-mortem brain: Alterations in limbic regions of schizophrenics
32. Neurotransmitter receptors in frontal cortex of schizophrenics
33. Brain beta-adrenoceptor binding sites in antidepressant-free depressed suicide victims
34. Increased serotonin2 and badrenergic receptor binding in the frontal cortices of suicide victims
35. Autoradiographic demonstration of increased serotonin 5-HT2 and B-adrenergic receptor binding sites in the brain of suicide victims
36. Regionally selective increases in b-adrenergic receptor density in the brains of suicide victims
37. Autoradiographic analysis of [3H] desmethylimipramine binding in the human brain postmortem
38. Laterality and 3H-imipramine binding: Studies in the frontal cortex of normal controls and suicide victims
39. Tritiated imipramine binding sites are decreased in the frontal cortex of suicides
40. A study of selected catecholamine metabolizing enzymes: A comparison of depressive suicides and alcoholic suicides with controls
41. Postmortem monoamine oxidase enzyme kinetics in the frontal cortex of suicide victims and controls
42. The density of monoamine oxidase B sites is not altered in the postmortem brain of alcoholics
43. Lowered monoamine oxidase activity in brains from alcoholic suicides
44. Selective increase of a2A-adrenoceptor agonist binding sites in brains of depressed suicide victims
45. Up-regulation of immunolabeled alpha2A-adrenoceptors, Gi coupling proteins, and regulatory receptor kinases in the pre-frontal cortex of depressed suicides
46. Agonist binding to a2-adrenoceptors is elevated in the locus coeruleus from victims of suicide
47. Increased p-[1251] iodoclonidine binding to a2-adrenoceptors in the locus coeruleus in major depression
48. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression
49. Quantitative distribution of monoamine oxidase A in brainstem monoamine nuclei is normal in major depression
50. Elevated tyrosine hydroxylase in the locus coeruleus of suicide victims
51. Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression
52. Reduced tyrosine hydroxylase immunoreactivity in locus coeruleus of suicide victims
53. Tyrosine hydroxylase immunoreactivity, in the locus coeruleus is reduced in depressed non-suicidal patients but normal in depressed suicide patients
54. Fewer pigmented locus coeruleus neurons in suicide victims: Preliminary results
55. Evidence for the locus coeruleus involvement in desipramine action in animal models of depression
56. Presynaptic modulation of beta adrenergic receptors in rat cerebral cortex after treatment with antidepressants
57. Localization and characterization of [3H] desmethylimipramine binding sites in rat brain by quantitative autoradiography
58. Molecular neuroanatomy of monoamine oxidases in human brainstem
59. Autoradiography of antidepressant binding sites in the human brain: Localization using [3H] imipramine and [3H]paroxetine
60. Antidepressant binding sites in the brain: Autoradiographic comparison of [3Hparoxetine and 3[H]imipramine localization and relationship to serotonin transporter
61. Effect of chronic administration of antidepressants on alpha 2-adrenoceptors in the locus coeruleus and its projection fields in rat brain determined by quantitative autoradiography
62. Coordinate regulation of the cyclic AMP system with firing rate and expression of tyrosine hydroxylase in the rat locus coeruleus: Effects of chronic stress and drug treatments
63. Behavioral depression produced by an uncontrollable stressor: Relationship to norepinephrine, dopamine, and serotonin levels in various regions of rat brain
64. Multiple apparent alpha-noradrenergic receptor binding sites in rat brain: Effect of 6-hydroxydopanline
65. Lesioning of serotoninergic and noradrenergic nerve fibers of the rat brain does not decrease binding of 3H-clonidine and 3H-rauwolscine to cortical membranes
66. Differential in vivo regulation of mRNA encoding the norepinephrine transporter and tyrosine hydroxylase in rat adrenal medulla and locus coeruleus
67. Recognition sites for norepinephrine uptake: Regulation by neurotransmitter
68. Regulation of subtypes of B-adrenergic receptors in rat brain following treatment with 6-hydroxydopamine
69. Quantitative autoradiography of central beta adrenoceptor subtypes: Comparison of the effects of chronic treatment with desipramine or centrally administered 1-isoproterenol
70. Neurocircuitry of mood disorders